Welcome to the Takeda Pharmaceutical Company Limited Q3 2025 Results Conference Call!
Company Participants:
– Christopher O’Reilly, Head, Investor Relations
– Christophe Weber, President and Chief Executive Officer
– Milano Furuta, Chief Financial Officer
– Andy Plump, President, R&D
Conference Call Participants:
– Stephen Barker, Jefferies
– Hidemaru Yamaguchi, Citi
– Mike Nedelcovych, TD Cowen
– Hiroyuki Matsubara, Nomura Securities
– Tony Ren, Macquarie
– Shinichiro Muraoka, Morgan Stanley
– Seiji Wakao, J.P. Morgan
– Hiroshi Wada, SMBC Nikko
– Kazuaki Hashiguchi, Daiwa Securities
– Miki Sogi, Bernstein
– Fumiyoshi Sakai, UBS
Christopher O’Reilly [Foreign Language]:
Let me start, I’d like to remind everyone that we’ll be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Now, let’s dive into the exciting world of pharmaceuticals and see what Takeda Pharmaceutical Company Limited has in store for us in Q3 of 2025!
With Christophe Weber leading the way as our President and Chief Executive Officer, we can expect big things from Takeda. His innovative approach to the industry has already led to significant advancements in research and development, thanks in part to the leadership of Milano Furuta as Chief Financial Officer and Andy Plump as President of R&D.
As we listen to the insights of our conference call participants, such as Stephen Barker from Jefferies and Mike Nedelcovych from TD Cowen, we can gain a better understanding of how Takeda is positioned in the market and where they are headed next.
Overall, the future looks bright for Takeda Pharmaceutical Company Limited, and we can’t wait to see what they have in store for us next!
How this will affect you:
As a consumer of pharmaceutical products, the advancements made by Takeda Pharmaceutical Company Limited in research and development could lead to new and improved treatments for a variety of medical conditions. This could potentially have a positive impact on your health and well-being in the future.
How this will affect the world:
The innovations brought forth by Takeda Pharmaceutical Company Limited have the potential to positively impact the global healthcare industry as a whole. With advancements in treatments and therapies, Takeda could contribute to improving the quality of life for people around the world and driving advancements in medical science.
Conclusion:
In conclusion, Takeda Pharmaceutical Company Limited is paving the way for a brighter and healthier future. With a strong leadership team and a focus on innovation, Takeda is poised to make a significant impact on the pharmaceutical industry and the world at large. We look forward to seeing what exciting developments the future holds for Takeda!
